148546-78-5Relevant articles and documents
5-HT RECEPTOR MODULATORS
-
, (2013/03/26)
The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
5-HT RECEPTOR MODULATORS
-
, (2011/09/15)
The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor 1B (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and componnds and compositions etc. for their treatment
Synthesis of potent and selective serotonin 5-HT1B receptor ligands
Huang, Yiyun,Bae, Sung-A.,Roth, Bryan L.,Laruelle, Marc
, p. 4786 - 4789 (2007/10/03)
A series of serotonin 5-HT1B ligands were synthesized and evaluated for their potency and selectivity against other 5-HT receptor subtypes. Many of these new compounds displayed high affinity and selectivity for the 5-HT1B receptor a
PIPERAZIDES DERIVED FROM ARYLPIPERAZINE, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
-
, (2008/06/13)
Novel 5HT receptor antagonists of general formula (I) STR1 in which Ar 1 and Ar 2 are aromatic residues, X is O, NH, CH 2 O, or CH 2 NH, and R 1 is hydrogen or linear or branched alkyl comprising 1-6 carbon atoms, as well as their salts, hydrates, solvate